Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Update on Adventrx's NDA for Exelbine

Oct. 4, 2011

Array BioPharma reports results from selumetinib NSCLC study

Oct. 4, 2011

New TTK inhibitors synthesized by Bayer Schering Pharma

Oct. 4, 2011

Threshold Pharmaceuticals begins pivotal study of TH-302

Oct. 4, 2011

Vernalis and Servier reach milestone in oncology collaboration

Oct. 4, 2011

Kancera products show activity against pancreatic cancer cells

Oct. 4, 2011

Children's Oncology Group and Apeiron to collaborate on phase II study in neuroblastoma

Oct. 3, 2011

Novel anticancer derivatives presented

Oct. 3, 2011

NanoCarrier and Kowa to enter worldwide agreement for NC-6300

Sep. 30, 2011

YM BioSciences starts phase II trial of CYT-387 in myelofibrosis

Sep. 30, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...